242 related articles for article (PubMed ID: 3492545)
1. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
Hamada A; Greene BM
J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545
[TBL] [Abstract][Full Text] [Related]
2. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
Moqbel R; Macdonald AJ; Cromwell O; Kay AB
Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro.
Moqbel R; MacDonald AJ; Kay AB
Clin Exp Immunol; 1985 Mar; 59(3):577-86. PubMed ID: 3987093
[TBL] [Abstract][Full Text] [Related]
5. Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni.
Khalife J; Dunne DW; Richardson BA; Mazza G; Thorne KJ; Capron A; Butterworth AE
J Immunol; 1989 Jun; 142(12):4422-7. PubMed ID: 2723436
[TBL] [Abstract][Full Text] [Related]
6. C1q enhancement of antibody-dependent granulocyte-mediated killing of nonphagocytosable targets in vitro.
Hamada A; Young J; Chmielewski RA; Greene BM
J Clin Invest; 1988 Sep; 82(3):945-9. PubMed ID: 2843577
[TBL] [Abstract][Full Text] [Related]
7. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
Moser G; Sher A
J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
[TBL] [Abstract][Full Text] [Related]
8. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.
Capron M; Kazatchkine MD; Fischer E; Joseph M; Butterworth AE; Kusnierz JP; Prin L; Papin JP; Capron A
J Immunol; 1987 Sep; 139(6):2059-65. PubMed ID: 2957447
[TBL] [Abstract][Full Text] [Related]
9. Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae.
Bickle QD; Ford MJ
J Immunol; 1982 May; 128(5):2101-6. PubMed ID: 7061855
[TBL] [Abstract][Full Text] [Related]
10. [The kinetics of cell-mediated cytotoxicity to schistosomula of Schistosoma japonicum with sera from infected mice at different duration].
Tao YW; Lui SX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(3):182-5. PubMed ID: 1959170
[TBL] [Abstract][Full Text] [Related]
11. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
Anwar AR; McKean JR; Smithers SR; Kay AB
J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978
[No Abstract] [Full Text] [Related]
12. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
13. Mouse antibody-dependent eosinophil and macrophage adherence and damage to schistosomula of Schistosoma mansoni.
Kassis AI; Aikawa M; Mahmoud AF
J Immunol; 1979 Feb; 122(2):398-405. PubMed ID: 762428
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IgG-triggered human eosinophil function by IL-4.
Baskar P; Silberstein DS; Pincus SH
J Immunol; 1990 Mar; 144(6):2321-6. PubMed ID: 2138196
[TBL] [Abstract][Full Text] [Related]
15. Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula.
Capron M; Rousseaux J; Mazingue C; Bazin H; Capron A
J Immunol; 1978 Dec; 121(6):2518-25. PubMed ID: 722083
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity.
Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB
Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415
[TBL] [Abstract][Full Text] [Related]
17. Human blood platelets possess specific binding sites for C1q.
Peerschke EI; Ghebrehiwet B
J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
[TBL] [Abstract][Full Text] [Related]
18. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
[TBL] [Abstract][Full Text] [Related]
19. Failure of anti-Fasciola antisera to induce antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula.
Hillyer GV; Richardson BA; Butterworth AE
J Parasitol; 1987 Aug; 73(4):774-7. PubMed ID: 3114465
[TBL] [Abstract][Full Text] [Related]
20. Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis.
López AF; Begley G; Andrews P; Butterworth AE; Vadas MA
J Immunol; 1985 Jun; 134(6):3969-77. PubMed ID: 3989303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
